Cipvision Prednisolone 1%

If you are pregnant, planning to become pregnant, or suspect pregnancy, consult your doctor before using Prednisolone Acetate. Your ophthalmologist can assess your eye condition and determine whether the expected benefits of treatment outweigh potential risks during pregnancy.

If you are breastfeeding, inform your doctor before using Prednisolone Acetate eye drops. Ophthalmic administration generally results in limited systemic exposure, although some absorption may occur. Your healthcare professional can advise whether treatment is appropriate while breastfeeding.

Prednisolone Acetate may temporarily cause blurred vision, stinging, or eye discomfort after application. Avoid driving, cycling, or operating machinery until your vision becomes clear and you can perform these activities safely. If blurred vision persists or worsens, contact your ophthalmologist.

Inform your doctor if you have kidney disease or reduced kidney function before using Prednisolone Acetate eye drops. Because this medicine is administered directly to the eye, systemic exposure is generally low, and kidney function is not usually expected to significantly affect ophthalmic treatment.

Tell your doctor if you have liver disease or impaired liver function before using Prednisolone Acetate. Ophthalmic administration generally produces limited systemic exposure, but your healthcare professional should consider your medical history and other medicines before recommending treatment.